The present invention relates to processes for the preparation of anhydrous form of benfotiamine.

The present invention relates to a process for the preparation of 3-[(1R)-2-chloro-1-hydroxyethyl]phenol of Formula II, an intermediate in the preparation of L-phenylephrine hydrochloride. The present invention further relates to the preparation of L-phenylephrine hydrochloride using 3-[(1R)-2-chloro-1-hydroxyethyl...

The present invention relates to a process for the preparation of anhydrous form of benfotiamine

The present invention relates to a process for the preparation of Fimasartan potassium trihydrate. The present invention more specifically relates to a process for the preparation of Fimasartan comprising thioamidation and detritylation of a compound of Formula II in the presence of a mixture of water and solvent. ...

The present invention relates to an improved process for the preparation of Luliconazole. The present invention also provides a novel intermediate 1-cyanomethylimidazole methanesulphonate of Formula (V), process for its preparation and its use for the preparation of Luliconazole.

The present invention relates to a process for the preparation of delafloxacin meglumine salt.

The present invention relates to a process for the purification of bilastine.

The present invention relates to an improved process for the preparation of bempedoic acid or its pharmaceutically acceptable salts. The present invention also provides novel salts of a compound of Formula II, a process for its preparation, and its use for the preparation of bempedoic acid or its pharmaceutically ac...

The present invention relates to an improved process for the preparation of 2-bromo-4,5-dimethoxybenzoic acid, an intermediate in the preparation of acotiamide hydrochloride trihydrate.